title: Evaluation of methods for testing the susceptibility of clinical Mycobacterium tuberculosis isolates to pyrazinamide.
abstract: Pyrazinamide (PZA) is a first-line antituberculosis (anti-TB) drug capable of killing nonreplicating, persistent Mycobacterium tuberculosis. However, reliable testing of the susceptibility of M. tuberculosis to PZA is challenging. Using 432 clinical M. tuberculosis isolates, we compared the performances of five methods for the determination of M. tuberculosis susceptibility to PZA: the MGIT 960 system, the molecular drug susceptibility test (mDST), the pyrazinamidase (PZase) activity assay, the resazurin microtiter assay (REMA), and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction test. The sensitivities of the MGIT 960 system, the PZase activity assay, the mDST, the REMA, and the MTT assay were 98.8%, 88.8%, 90.5%, 98.8%, and 98.2%, respectively. The sensitivities of the PZase activity assay and the mDST were lower than those of the other three methods (P < 0.05). The specificities of the MGIT 960 system, the PZase activity assay, the mDST, the REMA and the MTT assays were 99.2%, 98.9%, 90.9%, 98.5%, and 100%, respectively. The specificity of the mDST was lower than those of the other four methods (P < 0.05). In conclusion, the MGIT 960 system, the MTT assay, and the REMA are superior to the PZase activity assay and the mDST in determining the susceptibility of M. tuberculosis to PZA. The MTT assay and the REMA might serve as alternative methods for clinical laboratories without access to the MGIT 960 system. For rapid testing in well-equipped laboratories, the mDST might be the best choice, particularly for small quantities of M. tuberculosis. The PZase activity assay has no obvious advantage in the assessment of M. tuberculosis susceptibility to PZA, as it is less accurate and requires larger quantities of bacteria.
authors: Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Medical School, Tongji University, Shanghai, China.
authors: Zhenling
authors: Z
authors: Cui
authors: Jie
authors: J
authors: Wang
authors: Junmei
authors: J
authors: Lu
authors: Xiaochen
authors: X
authors: Huang
authors: Ruijuan
authors: R
authors: Zheng
authors: Zhongyi
authors: Z
authors: Hu
mesh_terms: D000581:Amidohydrolases / Q000032:analysis / Q000235:genetics; D000995:Antitubercular Agents / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial; D008826:Microbial Sensitivity Tests / Q000379:methods*; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D010078:Oxazines / Q000032:analysis; D011718:Pyrazinamide / Q000494:pharmacology*; D013778:Tetrazolium Salts / Q000032:analysis; D013844:Thiazoles / Q000032:analysis; D014966:Xanthenes / Q000032:analysis
chemical_list: D000995:Antitubercular Agents; D010078:Oxazines; D013778:Tetrazolium Salts; D013844:Thiazoles; D014966:Xanthenes; C005843:resazurin; D011718:Pyrazinamide; D000581:Amidohydrolases; C487496:PncA protein, Mycobacterium tuberculosis; C022490:pyrazinamide deamidase; C022616:thiazolyl blue
references: Microbiology (Reading). 1997 Oct;143 ( Pt 10):3367-3373
references: 9353938
references: PLoS One. 2011;6(11):e27654
references: 22102918
references: N Engl J Med. 1993 Sep 9;329(11):784-91
references: 8350889
references: Antimicrob Agents Chemother. 1989 Aug;33(8):1252-4
references: 2508544
references: BMC Infect Dis. 2011 Mar 29;11:78
references: 21443804
references: J Clin Microbiol. 2007 Jan;45(1):76-80
references: 17093022
references: Antimicrob Agents Chemother. 1988 Jul;32(7):1002-4
references: 3142340
references: Antimicrob Agents Chemother. 2000 Sep;44(9):2291-5
references: 10952570
references: J Clin Microbiol. 1998 May;36(5):1214-9
references: 9574679
references: Antimicrob Agents Chemother. 2011 May;55(5):2032-41
references: 21300839
references: J Antimicrob Chemother. 2010 Apr;65(4):704-12
references: 20118493
references: J Med Microbiol. 2005 Dec;54(Pt 12):1127-1131
references: 16278424
references: Mol Cell Probes. 2004 Jun;18(3):167-70
references: 15135450
references: Antimicrob Agents Chemother. 1983 Oct;24(4):600-1
references: 6418066
references: J Antimicrob Chemother. 2003 Nov;52(5):790-5
references: 14563891
references: J Clin Microbiol. 1995 Sep;33(9):2468-70
references: 7494049
references: Tubercle. 1985 Sep;66(3):219-25
references: 3931319
references: J Clin Microbiol. 2002 May;40(5):1670-4
references: 11980940
references: J Clin Microbiol. 2010 Jan;48(1):300-1
references: 19923479
references: J Microbiol Methods. 2003 Oct;55(1):331-3
references: 14500027
references: Bioinformation. 2011;6(9):335-9
references: 21814390
references: Am Rev Respir Dis. 1974 Jan;109(1):147-51
references: 4203284
references: Int J Tuberc Lung Dis. 2007 Jun;11(6):683-8
references: 17519102
references: Nucleic Acids Res. 1990 Jan 11;18(1):188
references: 2155396
references: Indian J Med Res. 2010 Jul;132:72-6
references: 20693593
references: Am Rev Tuberc. 1953 Mar;67(3):391-5
references: 13031058
references: PLoS One. 2011 Jan 24;6(1):e15785
references: 21283666
references: J Clin Microbiol. 2013 Jan;51(1):291-4
references: 23100351
references: Mem Inst Oswaldo Cruz. 2000 Jan-Feb;95(1):127-9
references: 10656718
references: Science. 2011 Sep 16;333(6049):1630-2
references: 21835980
references: Tuber Lung Dis. 1995 Dec;76(6):487-92
references: 8593368
references: Antimicrob Agents Chemother. 2012 Mar;56(3):1253-7
references: 22203587